Influence of proton pump inhibitors on nonsteroidal anti-inflammatory drug-induced small-intestinal lesions

Trial Profile

Influence of proton pump inhibitors on nonsteroidal anti-inflammatory drug-induced small-intestinal lesions

Discontinued
Phase of Trial: Phase I

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs Rabeprazole (Primary) ; Vonoprazan (Primary) ; Diclofenac
  • Indications Duodenal ulcer; Gastrointestinal ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jul 2017 Status changed from not yet recruiting to discontinued.
    • 17 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top